Literature DB >> 24193191

[Pharmacological therapy of arthrosis].

L M Wildi1.   

Abstract

The pharmacological management of osteoarthritis includes pure analgesia, anti-inflammatory drugs and substances supporting tissue maintenance in osteoarthritic joints. The decision for the treatment modality is made depending on the affected joint, the stage of the disease, the extent and frequency of inflammatory flares and the patient risk profile. This article gives an overview of the current treatment modalities including the advantages and disadvantages.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24193191     DOI: 10.1007/s00393-013-1280-0

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  46 in total

1.  Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial.

Authors:  Sandeep Patel; Mandeep S Dhillon; Sameer Aggarwal; Neelam Marwaha; Ashish Jain
Journal:  Am J Sports Med       Date:  2013-01-08       Impact factor: 6.202

2.  Morphological analysis of articular cartilage biopsies from a randomized, clinical study comparing the effects of 500-730 kDa sodium hyaluronate (Hyalgan) and methylprednisolone acetate on primary osteoarthritis of the knee.

Authors:  D D Guidolin; I P Ronchetti; E Lini; D Guerra; L Frizziero
Journal:  Osteoarthritis Cartilage       Date:  2001-05       Impact factor: 6.576

3.  Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study.

Authors:  Karel Pavelká; Jindriska Gatterová; Marta Olejarová; Stanislav Machacek; Giampaolo Giacovelli; Lucio C Rovati
Journal:  Arch Intern Med       Date:  2002-10-14

4.  Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.

Authors:  J Y Reginster; R Deroisy; L C Rovati; R L Lee; E Lejeune; O Bruyere; G Giacovelli; Y Henrotin; J E Dacre; C Gossett
Journal:  Lancet       Date:  2001-01-27       Impact factor: 79.321

5.  Hydroxychloroquine in the treatment of erosive osteoarthritis.

Authors:  L R Bryant; K F des Rosier; M T Carpenter
Journal:  J Rheumatol       Date:  1995-08       Impact factor: 4.666

6.  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.

Authors:  Daniel O Clegg; Domenic J Reda; Crystal L Harris; Marguerite A Klein; James R O'Dell; Michele M Hooper; John D Bradley; Clifton O Bingham; Michael H Weisman; Christopher G Jackson; Nancy E Lane; John J Cush; Larry W Moreland; H Ralph Schumacher; Chester V Oddis; Frederick Wolfe; Jerry A Molitor; David E Yocum; Thomas J Schnitzer; Daniel E Furst; Allen D Sawitzke; Helen Shi; Kenneth D Brandt; Roland W Moskowitz; H James Williams
Journal:  N Engl J Med       Date:  2006-02-23       Impact factor: 91.245

7.  Effect of sodium hyaluronate on prevention of osteoarthritis.

Authors:  N H Kim; C D Han; H M Lee; I H Yang
Journal:  Yonsei Med J       Date:  1991-06       Impact factor: 2.759

8.  A randomized, double-blind, placebo-controlled trial of low-dose oral prednisolone for treating painful hand osteoarthritis.

Authors:  Claire Y J Wenham; Elizabeth M A Hensor; Andrew J Grainger; Richard Hodgson; Sharon Balamoody; Caroline J Doré; Paul Emery; Philip G Conaghan
Journal:  Rheumatology (Oxford)       Date:  2012-09-06       Impact factor: 7.580

9.  Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification.

Authors:  Gust Verbruggen; Ruth Wittoek; Bert Vander Cruyssen; Dirk Elewaut
Journal:  Ann Rheum Dis       Date:  2011-11-29       Impact factor: 19.103

10.  Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial.

Authors:  Jean-Yves Reginster; Janusz Badurski; Nicholas Bellamy; William Bensen; Roland Chapurlat; Xavier Chevalier; Claus Christiansen; Harry Genant; Federico Navarro; Evgeny Nasonov; Philip N Sambrook; Timothy D Spector; Cyrus Cooper
Journal:  Ann Rheum Dis       Date:  2012-11-01       Impact factor: 19.103

View more
  1 in total

Review 1.  [Osteoarthritis: what internists should know].

Authors:  L Wildi
Journal:  Internist (Berl)       Date:  2015-05       Impact factor: 0.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.